Monte Rosa Therapeutics, Inc.
GLUE · XNASCIK 1826457fmd_019QK044RGEV7K1HQDGZ4NGM6WManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2020 to Sep 30, 2026, 27 periods
0 filings
From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).
Loading